News
MHRA deems Sanofi’s avalglucosidase alfa ‘promising’ for Pompe disease
The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has issued Sanofi a Promising Innovative Medicine (PIM) designation for avalglucosidase alfa in the treatment of Pompe disease.